As metabolic parameters reach unhealthy levels, there develops an inverse relationship with CTRP3, further supporting that CTRP3 is a beneficial hormone that decreases in obesity, as shown in the present study, and in other pathophysiological conditions such as diabetes and cardiovascular disease [27,29]. Here, C1QTNF3 is linked to obesity due to melanocortin 4 receptor deficiency.